Ashitaba Chalcone Extract

Ashitaba Chalcone Extract contains standardized concentrations of 4-hydroxyderricin and xanthoangelol, two chalcone compounds that activate AMPK pathways and hepatic FXR signaling to support metabolic function. These bioactive chalcones demonstrate anti-inflammatory effects through TNF-α inhibition and promote fatty acid oxidation while reducing bile acid synthesis.

Origin & History

Ashitaba Chalcone Extract is derived from the stems and leaves of Angelica keiskei, a plant native to Japan, particularly the Izu Islands. This concentrated extract isolates the unique chalcone compounds, offering targeted functional benefits for cellular health and metabolism.

Historical & Cultural Context

While Ashitaba itself has a long history in traditional Japanese medicine, Ashitaba Chalcone Extract is a modern concentrated isolate. Its value stems from traditional knowledge of the whole plant, with modern science isolating and validating the specific chalcone compounds for targeted benefits.

Health Benefits

- Provides potent antioxidant protection via chalcones, neutralizing free radicals and reducing oxidative stress.
- Exhibits significant anti-inflammatory properties, supporting cellular health and reducing systemic inflammation.
- Stimulates cellular regeneration and supports DNA repair, contributing to overall longevity.
- Enhances metabolic function, potentially aiding in blood sugar regulation.
- Offers neuroprotective benefits, supporting brain health and cognitive function.

How It Works

The primary chalcones 4-hydroxyderricin and xanthoangelol activate AMPK pathways, inactivating acetyl-CoA carboxylase to promote fatty acid oxidation via CPT-1A. These compounds upregulate adiponectin mRNA expression up to 8.27-fold and activate hepatic FXR signaling, which represses CYP7A1 by 38.8% and SCD-1 by 43.8% to inhibit bile acid synthesis and de novo fatty acid production. Anti-inflammatory effects occur through TNF-α inhibition and apoptosis induction in abnormal cells.

Scientific Research

Research focuses on the isolated chalcone compounds, particularly xanthoangelol and 4-hydroxyderricin, demonstrating their potent antioxidant, anti-inflammatory, and metabolic-supportive effects in in vitro and animal studies. Further human clinical trials are exploring their full therapeutic potential.

Clinical Summary

Human clinical trials have demonstrated anti-obesity effects in both men and women, though specific weight loss percentages were not quantified in available studies. Preclinical studies in high-fat diet mouse models showed FXR expression increased 1.58-fold with corresponding reductions in CYP7A1 and SCD-1 enzymes. Safety studies in mice confirmed safe absorption of both primary chalcones at doses up to 1000 mg/kg daily for three days without adverse effects. Current evidence is primarily from animal studies with limited human clinical data available.

Nutritional Profile

- Chalcones: Xanthoangelol, 4-Hydroxyderricin (potent anti-inflammatory, antioxidant, and metabolic agents)
- Vitamins: B12 (essential for energy production and nervous system function)
- Polyphenols: (reduce oxidative stress and support cardiovascular health)

Preparation & Dosage

- Common forms: Liquid extract, capsules, powder.
- Dosage: 1-2 ml liquid extract daily; 500 mg capsules once or twice daily with meals; 1 tsp powder in smoothies or juices.
- Timing: Best taken with meals for optimal absorption.

Synergy & Pairings

Role: Polyphenol/antioxidant base
Intention: Immune & Inflammation | Longevity & Anti-Aging
Primary Pairings: - Green Tea (Camellia sinensis)
- Turmeric (Curcuma longa)
- Vitamin C (Ascorbic Acid)
- Moringa (Moringa oleifera)

Safety & Interactions

High-dose studies in rats (1000 mg/kg/day) showed significant increases in serum alkaline phosphatase, total cholesterol, phospholipids, and triglycerides, with some animals developing jejunal lymphangiectasia. Elevated AST levels occurred in high-dose female subjects, though the clinical significance remains unclear. No genotoxicity was observed in chromosomal aberration tests, and no drug interactions or contraindications have been specifically identified in current research. Pregnant and nursing women should avoid use due to insufficient safety data in these populations.